Phase III Study of Atamestane Plus Toremifene in Metastatic Breast Cancer
Phase of Trial: Phase III
Latest Information Update: 15 May 2014
At a glance
- Drugs Atamestane (Primary) ; Toremifene
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Intarcia Therapeutics
- 14 Jun 2008 Status changed from in progress to discontinued, as reported by ClinicalTrials.gov.
- 09 Sep 2005 New trial record.